Concerning the debate about homocysteine, B vitamins, and dementia

It is important to identify modifiable risk factors for dementia and to introduce policies to implement their modification. The Lancet Commission on Dementia Prevention, Intervention and Care failed to identify raised plasma homocysteine as a risk factor, despite considerable evidence; hence there i...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Alzheimer's disease Vol. 106; no. 3; p. 920
Main Authors: Miller, Joshua W, McCaddon, Andrew, Yu, Jin-Tai, Hooshmand, Babak, Refsum, Helga, Smith, A David
Format: Journal Article
Language:English
Published: United States 01.08.2025
Subjects:
Dementia - blood
Dementia - prevention & control
Homocysteine - blood
Humans
Risk Factors
Vitamin B Complex
homocysteine
folate
B12
B6
dementia
Alzheimer's disease
risk factor
ISSN:1875-8908, 1875-8908
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:It is important to identify modifiable risk factors for dementia and to introduce policies to implement their modification. The Lancet Commission on Dementia Prevention, Intervention and Care failed to identify raised plasma homocysteine as a risk factor, despite considerable evidence; hence there is a need for a debate on this matter.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1875-8908
1875-8908
DOI:10.1177/13872877251350297